Dexamfetamine, an amphetamine derivative, is carefully controlled in Australia due to its potential for abuse . Its usage is primarily restricted to management of attention-deficit hyperactivity disorder (ADHD) in patients and, infrequently , for excessive daytime sleepiness . Medical authorizations